March 13, 2018 by Chain Drug Review
Andrew Witty, David Wichmann, GlaxoSmithKline, Larry Renfro, Optum, OptumRx, UnitedHealth Group
Business, Leading Headlines, Pharmacy, Supplier News
MINNEAPOLIS — Former GlaxoSmithKline plc chief executive officer Sir Andrew Witty has been named CEO of Optum, the health services, technology and pharmacy benefits management unit of health insurance giant UnitedHealth Group. Plans call for Witty to start as Optum CEO on July 1. He takes over from Larry Renfro, vice chair of UnitedHealth Group, who has
April 4, 2016 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, Drug Channels Institute, Larry Renfro, OptumRx, PBMs, Pembroke Consulting, pharmacy care, Walgreens, Walgreens Boots Alliance
2016, Issue 04-04-2016, Issues, News
DEERFIELD, Ill. — Walgreens is partnering with OptumRx to create a new pharmacy benefit to meet consumers’ changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings. OptumRx is UnitedHealth Group’s freestanding pharmacy care services business, managing more than a billion prescriptions annually. Through a
March 17, 2016 by Chain Drug Review
Alex Gourlay, Larry Renfro, OptumRx, PBM, pharmacy benefit manager, pharmacy care, prescription drug services, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. and EDEN PRAIRIE, Minn. — Walgreens and pharmacy benefit manager OptumRx are collaborating on an an integrated pharmacy care solution that blends attributes of in-store and mail-order prescription drug services. The companies said Thursday that OptumRx members enrolled in the program will get the option to fill 90-day prescriptions at home delivery co-payment levels at
March 30, 2015 by Chain Drug Review and Chain Drug Review
Catamaran Corp., Larry Renfro, Mark Thierer, Optum, OptumRx, PBM, pharmacy benefit management, Timothy Wicks, UnitedHealth Group
Business, Leading Headlines, Pharmacy, Retail News
NEW YORK and SCHAUMBURG, Ill. — Reflecting the ongoing consolidation in the pharmacy benefit management (PBM) sector, UnitedHealth Group plans to acquire Catamaran Corp. in a deal valued at $12.8 billion. The companies said Monday that Catamaran would integrated into OptumRx, UnitedHealth’s freestanding pharmacy care services business and part of its Optum health services unit.